Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 232
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dylan Beynon – Mindbloom – At Home Ketamine
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans
Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model
Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout
Awakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release...
Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of...
MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT...
MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and...
Psilocybin for Depression: A Q&A between Robin Carhart-Harris & a Psilocybin...
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.
Creso Pharma and Red Light Holland Merge to Introduce The HighBrid...
1
...
231
232
233
...
291
Page 232 of 291